Riemser Arzneimittel AG
Riemser Arzneimittel AG is a company with tradition and a future.
Following its demerger from the Friedrich-Loeffler-Institute Riems Island (FLI), Riemser Arzneimittel AG has, within a period of just a few years, evolved to become one of East Germany’s largest producers and developers of pharmaceutical products.
It has affiliated branches in such German Federal States such as Saarland, Baden-Württemberg, and Saxony as well as abroad and more than 618 employees at various locations.
Riemser Arzneimittel AG exports to more than 80 countries, including China, Russia and the U.S.A and business transacted abroad is more than 40 percent of total sales.
Riemser carries a well-diversified portfolio, which encompasses the areas human, veterinary, and dental.
More information on www.riemser.com.